Boothbay Fund Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,069
| Closed | -$60.4K | – | 1942 |
|
|
2023
Q2 | $60.4K | Hold |
2,069
| – | – | ﹤0.01% | 1440 |
|
|
2023
Q1 | $47.7K | Hold |
2,069
| – | – | ﹤0.01% | 1775 |
|
|
2022
Q4 | $29.8K | Hold |
2,069
| – | – | ﹤0.01% | 1658 |
|
|
2022
Q3 | $50K | Sell |
2,069
-218
| -10% | -$5.27K | ﹤0.01% | 1830 |
|
|
2022
Q2 | $45K | Hold |
2,287
| – | – | ﹤0.01% | 1816 |
|
|
2022
Q1 | $82K | Hold |
2,287
| – | – | ﹤0.01% | 1744 |
|
|
2021
Q4 | $102K | Sell |
2,287
-2,410
| -51% | -$107K | ﹤0.01% | 1551 |
|
|
2021
Q3 | $334K | Buy |
4,697
+1,424
| +44% | +$101K | 0.01% | 1062 |
|
|
2021
Q2 | $432K | Hold |
3,273
| – | – | 0.01% | 945 |
|
|
2021
Q1 | $439K | Sell |
3,273
-2,014
| -38% | -$270K | 0.02% | 817 |
|
|
2020
Q4 | $387K | Buy |
+5,287
| New | +$387K | 0.01% | 713 |
|